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INTRODUCTION AND AIMS OF THE DISSERTATION 
Enterobacter cloacae is an opportunistic pathogen that is recognised increasingly in 
patients with nosocornial infection. Although E. cloacae is notorious for its 
involvement in common-source outbreaks (Maki 1976), most hospital isolates are 
from sporadic infections, or colonisations, of patients. An increase in the rate of 
isolation of E. cloacae need not identify a common-source outbreak, but rather may 
be the result of coincidental isolations, each isolate having been selected from a 
patient's flora by the use of a third-generation cephalosporin (Gaston 1988). 
Resistance may emerge in E. cloacae to previously effective beta-lactam antibiotics, 
including second- and third-generation cephalosporins, monobactams and broad-
spectrum penicillins. The spread amongst hospital patients of such resistant E. 
cloacae and the therapeutic failures associated with the emergence of resistance are 
of grave concern (Sanders 1982, 1987). 
The percentage of isolates of E. cloacae that are resistant to third-generation 
cephalosporins is higher when the isolates are from patients in a tertiary-level 
hospital, as opposed to a community hospital (15% and 4%, respectively) (Ellner 
1987). Amongst patients in similar units of tertiary-level hospitals, isolates from 
patients in the hospital that dispenses the greater amount of cephalosporins are 
more commonly ( 10% versus 1 % ) resistant to third-generation cephalosporins 
(Benn 1984 ). Control of the use of cephalosporins in tertiary-level hospitals has 
been advocated to prevent the emergence and spread of resistant E. cloacae 
(Sanders 1985, 1987). 
Groote Schuur Hospital is a tertiary-level hospital with an antibiotic policy that 
includes restricted access to cephalosporins. Surveillance in the Medical 
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Microbiology Laboratory of Groote Schuur Hospital suggests that less than 10% of 
isolates of E. cloacae from patients in Groote Schuur Hospital are resistant to third-
generation cephalosporins. 
The aims of the dissertation are 
(1) to determine the proportion of isolates of.E. cloacae from Groote Schuur 
Hospital inpatients that are resistant to third-generation cephalosporins 
(2) to determine this proportion using methods suitable for continued use in 
the routine laboratory. 




1. INTRODUCTION TO LITERATURE REVIEW 
Investigation of the resistance to cefamandole and to cefotaxime that may 
emerge in Enterobacter cloacae has contributed to an increased 
understanding of the roles of bacterial ce~l wall permeability and of beta-
lactamase activity in the resistance of Gram negative bacilli to beta-lactam 
antibiotics (Vu 1985). 
Cefamandole, a second-generation cephalosporin, was found to be more 
active than ampicillin (a broad-spectrum penicillin) and cephaloridine (a 
first-generation cephalosporin) against Enterobacter species (Eykyn 1973). 
However, discrepancies in determinations of the minimum inhibitory 
concentration (MIC) of cefamandole for Enterobacter species suggested that 
resistance could emerge and that this resistance was enzyme-mediated 
(Findell 1976). 
Although induction of increased beta-lactamase activity by benzylpenicillin 
was known to occur m fEnterobacter cloacae (Hennessey 1967), 
cefamandole could not be shown to induce increased beta-lactamase 
activity (Ott 1979). Sanders (1979) showed that resistance to cefamandole 
emergedin E. cloacae cultured in the presence of cefoxitin, and was due to 
induction of increased beta-lactamase activity. Clinical failures of therapy 
-
were identified and were accompanied by the isolation of cefamandole 
resistant Enterobacter species (Sanders 1982), but in these isolates increased 
beta-lactamase activity followed a genetic mutation and persisted in the 
absence of an inducer (Gootz 1982). 
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Increased beta-lactamase activity was considered to be the sole mechanism 
for the resistance to cefamandole of Enterobacter species. Cefotaxime, a 
third-generation cephalosporin, was thought not to be hydrolysed by the 
beta-lactamase from E. cloacae, so that when cefotaxime resistant E. 
cloacae were identified, a novel form of resistance seemed likely (Then 
1982). 
2. BET A-LACT AM ANTIBIOTIC ACTION 
Penicillin-binding proteins (PBPs) are located in the periplasmic space of 
Gram negative bacteria and include enzymes that are essential for cell wall 
assembly. PBPs catalyse the transpeptidase reaction that cross-links cell 
wall peptidoglycan subunits. The D-alanyl-D-alanine bond, the target for 
this reaction, and the amide bond of the beta-lactam ring are similar in 
structure. This allows the active site of the PBPs to bind to beta-lactam 
antibiotics (Chambers 1986) and results in inactivation of both beta-lactam 
antibiotic and PBPs (Nayler 1987). When sufficient essential PBPs are 
inactivated then cell wall assembly is prevented. Thus, to be effective, beta-
lactam antibiotics not only must reach the periplasmic space, but also must 
accumulate there to achieve a minimum inhibitory concentration (Nikaido 
1987). 
3. OUTER MEMBRANE PERMEABILITY 
The outer membrane of Gram negative bacilli is composed of an outer 
leaflet of lipopolysaccharide and an inner leaflet of phospholipids. This 
structure is hydrophobic and diffusion of hydrophilic substances through the 
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outer membrane is slow. General diffusion porins, such as outer membrane 
protein F (OmpF), are water-filled protein channels that traverse the outer 
membrane and allow rapid diffusion of hydrophilic substances, with 
molecular weights below 650 daltons, between the exterior of the cell and 
the periplasmic space (Benz 1988). 
3 .1 Cephalosporin diffusion 
Cephalosporin entry into the periplasmic space is most rapid when diffusion 
across the outer membrane is via the general diffusion porins. The rate of 
diffusion through these porins is reduced when the cephalosporin is 
negatively charged or hydrophobic or has bulky side chains (Nikaido 1983, 
Yoshimura 1985). 
(The following discussion is summarised, in part, in Figure 1.) 
Monoanionic beta-lactam antibiotics (in order of increasing 
hydrophobicity) cephacetrile, cefazolin, cefmetazole, cefoxitin and 
cefamandole show a linear (inverse) relationship between hydrophobicity 
and rate of diffusion. The rate of diffusion of cefamandole is about one 
fifth of that of cephacetrile. 
Monoanions with an oxime group ( cefotaxime, ceftizoxime and cefuroxime) 
or an ureido group ( cefoperazone) in the position 7 side chain are as 
hydrophilic as cephacetrile but diffuse as slowly as cefamandole. 
Dianionic cephalosporins (moxalactam and ceftriaxone) and azthreonam 
are hydrophilic but diffuse at rates similar to cefoxitin and cefamandole. 
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Compounds with one positive and two negative charges that are hydrophilic 
( cephalosporin c and cefsulodin) have rates of diffusion similar to 
hydrophilic monoanions. Ceftazidime, which is hydrophobic and has an 
oxime group in the position 7 side chain, has a rate of diffusion similar to 
cefamandole. 
Cephalosporins that are zwitterionic ( cephaloridine, cephaloglycin, 
cephalexin and cefaclor) still have higher rates of diffusion than cefacetrile, 
even though they are hydrophobic. 
Di polar ionic methoxyirnino-cephalosporins ( cefpirome, cefepime and E-
1040) are hydrophobic and bulky, and are predicted to diffuse at rates 
similar to cefoxitin (Nikaido 1990). 
Irnipenem 1s zitterionic, hydrophilic (hydrophilicity is similar to 
azthreonam) and has a high rate of diffusion, at least twice that of 
cephacetrile. 
3.2 Diffusion of broad-spectrum penicillins 
Broad-spectrum penicillins (ampicillin, amoxycillin, piperacillin and 
apalcillin) are as hydrophobic as cephaloridine and cefazolin. However, 
diffusion rates for these penicillins in the absence of porins are higher than 
for cephalosporins of comparable hydrophobicity (Yamaguchi 1983, 1985). 
Absence of OmpF raises the MICs of cephalosporins for Escherichia coli 
two- to three-fold, but there is no comparable increase in resistance to 
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ampicillin and piperacillin. These penicillins appear to have a reduced 
dependency on the OmpF pathway for entry into the cell (Hiraoka 1989). 
4. BETA-LACTAMASES 
Beta-lactamases are enzymes that inactivate beta-lactam antibiotics. The 
beta-lactamases of most Gram negative b_acilli, including E. cloacae, have 
serine at the active site of the enzyme. Formation of a covalent bond 
between this serine and the ester group of the beta-lactam ring inactivates 
the beta-lactam antibiotic (and the beta-lactamase). The antibiotic either 
remains "trapped" as an enzyme-substrate complex (Graham 1989) or the 
serine-ester bond is broken, with beta-lactamase regeneration and 
antibiotic hydrolysis (Nayler 1987). 
The beta-lactamases of Gram negative bacilli are located in the periplasmic 
space. If the rate that they inactivate beta-lactam antibiotic entering the 
periplasmic space is sufficient to maintain the periplasrnic concentration of 
the antibiotic below the MIC for the essential PBPs, then the bacterium is 
resistant to the antibiotic. Thus the protective effect to the bacterium is a 
synergy between the activity of the periplasrnic beta-lactamase and the 
diffusion barrier provided by the cell wall (Zimmermann 1977, Vu 1985). 
4.1 Hydrolytic activity 
-
The hydrolytic activcity of an enzyme (beta-lactamase) is measured as a 
rate, the number of millimoles of substrate (beta-lactam antibiotic) 
hydrolysed per minute at stated conditions of pH and temperature. The 
rate of hydrolysis by a fixed amount of enzyme increases with increasing 
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substrate concentration until the substrate saturates the enzyme, when the 
rate of hydrolysis becomes proportional to the amount of enzyme. The 
choice of an initial substrate concentration (S0 ) appropriate to the 
experiment is, therefore, important (Vu 1985, Wharton 1981, Bush 1986 
and 1989a). 
Jack (1970), choosing S0 to obtain enzw1e saturation, found that beta-
lactamases from Gram negative bacilli could be distinguished by their rates 
of hydrolysis of benzylpenicillin, ampicillin and cephaloridine. (These 
"substrate profiles" were the foundation of the Richmond and Sykes 
classification (Sykes 1982) of beta-lactamases.) 
The term "cephalosporinase" was used to describe the beta-lactamase from 
E. cloacae which, with S0 0, 1 to 6 mM, hydrolysed cephaloridine 80 times 
faster than benzylpenicillin (Jack 1970). Results of subsequent experiments 
with this beta-lactamase, designed to determine the Michaelis-Menten 
parameters of the hydrolytic reaction suggested that substrate inhibition of 
the beta-lactamase occurred at S0 0,1 mM (Minami 1980b, Seeberg 1983) 
and drew attention to the importance of the S0 chosen. 
Vu and Nikaido (1985) measured rates of hydrolysis using S0 of 1,0 to 100 
micromoles. They concluded that Michaelis-Menten parameters based on 
the results of measurements with S0 above 2,0 micromoles were inaccurate 
(possibly due to substrate inhibition of enzyme). Michaelis-Menten 
-
parameters based on rates of hydrolysis with S0 1,0 micromole showed that 
with S0 0, 1 and 1,0 micromoles the differences between the rates of 
hydrolysis calculated for cefazolin and cefotaxime were small, compared to 
the differences at higher S0 . 
8 
Furthermore, as the MICs of cephalosporins for PBPs are thought to be 
between 0, 1 and 1,0 rnicromoles, the rates of hydrolysis at lower S0 are 
those that are physiologically relevant (Vu 1985, Nikaido 1989). 
These were important findings: Figure 2 shows the rates of hydrolysis of 
cefamandole, cefoxitin, cefotaxime and . cefpirome at S0 0, 1 to 100 
rnicromoles by the beta-lactamase of E. cloacae. 
4.2 Genetic control of beta-lactamase expression 
The structural gene for beta-lactamase, ampC, is highly conserved amongst 
members of the Enterobacteriaceae (Bergstrom 1982). 
In E. coli and Shigella sonnei, ampC is located adjacent to frdD, one of the 
genes for the fumarate reductase complex (Normark 1986, Linderberg 
1986). 
In Citrobacter freundii, the 1,2 kb region which separates frdD and ampC is 
required for induction of beta-lactamase overproduction (~ergstrom 1983). 
The region contains ampR, which codes for a regulatory protein, AmpR 
(Lindberg 1985). Honore (1986) sequenced ampR from E. cloacae and 
located the promotors for ampR and ampC. 
-
In C. freundii, AmpR activates ampC transcription and -suppresses ampR 
transcription. AmpR binds to a 38 bp region that, in E. cloacae, would 
precede the promotor for ampC and overlap the promotor for ampR 
(Lindquist 1989). Gene sequences predict that the AmpR has an amino 
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terminal helix-turn-helix DNA binding motif and places AmpR in the Lys R 
family of activator proteins (Henikoff 1988). 
Inactivation of a distinct gene, ampD, is followed by constitutive 
overproduction of beta-lactamase, provided ampR is present (Lindberg 
1987). Another gene, ampG, is required for both constitutive and induced 
overproduction of beta-lactamase, and mfLy process a signal that activates 
ampR (Korfmann 1989). 
5. CEPHALOSPORIN RESISTANCE OF E. CLOACAE 
A minimum concentration of cephalosporin in the periplasmic space is 
required to inhibit essential PBPs. If accumulation of cephalosporin in the 
periplasmic space is prevented, then the bacterium will be resistant to the 
antibiotic. 
In E. cloacae two factors interact to prevent accumulation of second- and 
third-generation cephalosporins:-
(1) The outer membrane of E. cloacae is 10-14 times less permeable to 
cephalosporins than that of E. coli (Nikaido 1983, Yoshimura 1985, 
Nayler 1987). 
(2) The beta-lactamase of E. cloacae hydrolyses second- and third-
-
generation cephalosporins with equal rapidity at the low 
concentrations found in the periplasmic space (Vu 1985, Yang 1988). 
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The chromosomally-encoded beta-lactamase of E. cloacae is not inhibited 
by clavulanate (10 mg/L) and has a pl of 7,8-8,8 on isoelectric focusing 
(Matthew 1975, Bush 1989a,b ). 
Resistance to cephalosporins emerges in E. cloacae when beta-lactamase 
activity increases following induction or mutation (Gootz 1982) and is due 
to overproduction of the beta-lactamase {Graham 1989). The amount of 
beta-lactamase in the bacterial cell increases 2-700 fold with induced 
overproduction and 1 000-30 000 fold with constitutive overproduction 
(Then 1986 and 1987, Graham 1989). 
Strength of induction and stability to beta-lactamase determine the form of 
resistance that is most likely to emerge with use of a particular beta-lactam 
antibiotic (Livermore 1987a,b ). 
Strong inducers that are labile, such as cefoxitin and ampicillin, promote 
their own destruction. In contrast, weak inducers that are labile will remain 
effective until a mutant arises that constitutively overproduces beta-
lactamase. Thus the survival advantage to the bacterium of this mutation is 
high with exposure to this group of antibiotics, which includes cefamandole, 
cefuroxime, third-generation cephalosporins and ureidopenicillins (Minami 
1980a, Then 1987, Yang 1988). 
Decreases in outer membrane permeability that coincide with increased 
beta-lactamase production may contribute to the resistance that emerges. 
The contribution to resistance of a four fold increase in permeability is 
difficult to assess when there is constitutive overproduction of beta-
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lactamase (Marchon 1987, Graham 1989) but might increase the cefotaxime 
MIC from 32 to 64-128 mg/L (Hopkins 1990). 
In mutants that constitutively produce low levels of beta-lactamase, changes 
in permeability raise the cefotaxime MIC from 0,12 to 1,0 mg/L (Werner 
1985, Then 1986). 
6. SCREENING TESTS 
Tests suited to the routine laboratory that will identify induced and 
constitutive overproduction of beta-lactamase by E. cloacae are discussed. 
6.1 Induction tests 
Sanders (1979) selected three isolates of Enterobacter species to define 
criteria that identified induction in a disc approximation test. Crude 
extracts of these isolates showed hydrolysis of cefamandole when growth 
had taken place in the presence of cefoxitin, but no hydrolysis when the 
cefoxitin had been omitted from the growth medium. In the disc 
approximation test, discs containing antibiotics were placed on an agar 
plate inoculated with a suspension of the isolate of Enterobacter species. A 
disc containing cefoxitin (30 microgrammes) was positioned to be at the 
edge of the zone of inhibition about a disc containing cefamandole (30 
microgrammes). The radius of the zone of inhibition about the 
cefamandole disc was reduced by at least 4 mm for the three isolates 
selected, and this reduction was attributed to induction of increased beta-
lactamase activity. Using 4 mm as a minimum reduction, induction was 
identified in 29 /33 isolates of Enterobacter species resistant to cefoxitin. 
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Mulgrave (1985) determined the agar dilution MIC of cefotaxime for 
Enterobacter species with and without sub-inhibitory concentrations of 
cefoxitin in the agar, and identified induction if the cefotaxime MIC was 4 
fold higher when cefoxitin was present. Chandler (1987) found improved 
correlation between this test and a cefotaxime-cefoxitin disc approximation 
test when induction was identified by any r~duction in the inhibition zone. 
Ashby (1987) demonstrated beta-lactamase activity by an additional 
method. In their disc approximation test, colour change in a drop of 
nitrocefin solution placed on growth near the reduced part of the zone of 
inhibition was compared to that obtained on growth in an antibiotic-free 
area. The inducer used was either imipenem (10 microgramme disc) or 
cefoxitin (30 microgramme disc). Both imipenem and cefoxitin are potent 
inducers (at 1 and 10 mg/L concentrations, respectively) that increase beta-
lactamase activity 100 - 300 fold (Yang 1988). 
Thore (1989) altered conditions of the disc approximation test until the 
number of isolates that showed a reduction in the inhibition zone reached a 
maximum, but concluded that sensitivity, specificity and appropriate criteria 
for the interpretation of disc approximation tests of induction are not 
known. 
6.2 Detection of expanded-spectrum beta-lactamases 
Plasmid-encoded beta-lactamases that are common m Gram negative 
bacilli, such as TEM-1 beta-lactamase, may be found in E. cloacae but do 
not confer resistance to cefotaxime (Seeberg 1983). 
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Plasmid-encoded expanded-spectrum beta-lactamases, identified m 
Klebsiella ozaenae in 1983, on the evidence of nucleotide sequencing, are 
derived from TEM-1 and TEM-2 or from SHV-1 beta-lactamases. These 
beta-lactamases confer moderate levels of resistance to third-generation 
cephalosporins (Philippon 1989). In Klebsiella pneumoniae the cefotaxime 
MIC may be raised from 0,1 mg/L to b.etween 2 and 64 mg/L (Jarlier 
1988). 
Clavulanic acid (10 mg/L) inhibits the hydrolytic activity of the extended-
spectrum beta-lactamases (Bush 1989b ). A clavulanate-cefotaxime disc 
approximation test ("the clavulanate inhibition test") has been used to 
detect these beta-lactamases (Brun-Buisson 1987, Ben Redjeb 1988). 
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EXPERIMENTAL WORK 
MATERIALS AND METHODS 
Bacterial isolates 
Enterobacter cloacae isolates were obtained fr_om the Medical Microbiology 
Laboratory at Groote Schuur Hospital. Isolates (41) from diagnostic specimens had 
been collected at random in the Routine Laboratory ( during February-April 1989) 
and in the Emergency Laboratory (during January-June 1989). Isolates (91) from 
surveillance cultures of gastro-intestinal and respiratory tract flora were collected 
sequentially (from February to August 1989). 
Other bacteria were Escherichia coli (NCTC 10418) and isolates of Salmonella 
typhimurium, Serratia marcescens, Proteus vulgaris, Shigella flexneri, Pseudomonas 
aemginosa ( ceftazidime and piperacillin susceptible and resistant), Haemophilus 
influenzae (amoxycillin susceptible, and resistant) and Klebsiella pneumoniae 
( resistant and moderately susceptible to cefotaxime) ( collected by R Bohmer) from 
diagnostic specimens submitted to the Medical Microbiology Laboratory. 
Identification of Enterobacter species 
Standard methods of identification were used (Cowan 1974, Farmer III 1985a,b, 
Brenner 1986, Ewing 1986). Ornithine and lysine decarboxylase and arginine 
decarboxylase/dehydrolase tests were incubated for three days (Piisucki 1979). 
Details of the identification procedure are given in Figures 3 and 4. 
1 5 
Part of the colony used for identification was inoculated onto a Dorset egg slope and 
was the source for subsequent or repeated tests. 
Antibiotics 
Commercially prepared discs containing antibiotic (Mast Laboratories, Merseyside, 
UK), stored dessicated at 4-8°C, were used in tests of susceptibility, induction and 
inhibition. Contents of discs used in susceptibility and induction tests are given in 
Table 1. 
Nitrocefin powder reconstituted with buffer (Oxoid Laboratories, Basingstoke, 
Hampshire, UK) was diluted to 0,5 mg/ml with distilled water. Cefotaxime sodium 
for parenteral use BPC (Roussel Laboratories, Santon, RSA) powder was made up 
to 2mg/ml with distilled water. Stock solutions of nitrocefin and cefotaxime were 
stored at -20°C. 
Plate inoculation 
Isosensitest agar (Oxoid Laboratories) plates were inoculated uniformly as follows; 
a suspension of bacteria in peptone water was adjusted to give an inoculum that, 
when spread with a dry swab, gave semi-confluent growth after 18 hours incubation 
at 37°C . This method is the same as that described for Stokes' comparative 
method (Stokes 1980). 
Susceptibility tests 
Discs containing antibiotic were applied to the surface of the agar. Peripheral 
inoculation of E. coli (NCTC 10418), or in some instances S. typhimurium was used 
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to control disc potency. After 18 hours incubation, the diameter of the zone of 
growth inhibition about the disc was measured with a microcaliper. 
To estimate susceptibility, the zone diameters obtained using this method were 
compared to limits defining resistance (~ n) and susceptibility (~ n) prescribed in 
the Medical Microbiology Laboratory, Groote Schuur Hospital (Table 1). 
Validation of this method was sought, for cefotaxime, by determining the minimum 
inhibitory concentration (MIC) of cefotaxime for 8 isolates of E. cloacae using a 
macro-method (Sanders 1985) with dilution of cefotaxime in Mueller-Hinton broth 
(Reeves 1978). 
Induction tests 
A disc approximation test (Sanders 1979) was used, with the following modifications 
(Chandler 1987, Thore 1989):-
With cefoxitin and imipenem as inducers and cefamandole as the indicator, 
flattening of the zone of growth inhibition about the indicator disc, seen adjacent to 
an inducer disc, was interpreted as a positive test, and as suggesting the induced 
overproduction of beta-lactamase. 
Preliminary tests, done to select the distance between the discs containing inducer 
and indicator, used eight isolates of E. cloacae chosen at random. Zone reduction 
-
was present when the cefamandole disc was ( disc center to disc center, 6 mm 
diameter discs) 22-25 mm from the cefoxitin disc and 26-30 mm from the imipenem 
disc. Distances of 22 mm (cefoxitin-cefamandole) and 28 mm (imipenem-
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cefamandole) gave maximum zone reductions for the eight isolates and were used in 
all subsequent induction tests. 
Determination of isoelectric points 
(a) Extraction of beta-lactamase 
Overnight peptone water culture (5 ml) of E. cloacae or P. aeruginosa was 
added to 25 ml of Luria broth in a 250 ml bottle and incubated at 37°C, 
with aeration, for 4 hours (Minami 1980b ). For H influenzae, overnight 
growth on a boiled-blood agar plate was added to boiled-blood broth and 
incubated in 5% CO2 in air, with intermittant shaking. 
Bacterial cells were harvested by centrifugation at 2000 rpm at 4-8°C for 45 
minutes in a Beckman 12-21 centrifuge with a JA-20 fixed-angle rotor. The 
pellet was washed by suspension in 10 ml of 0, 1 M phosphate buffer pH 7,0 
and centrifugation as described before (Yang 1988). 
Cells, suspended in 5,5 ml of the phosphate buffer, were held on melting ice 
during sonication. A Virsonic cell disruptor (Model 16-850, Virtis, 
Gardiner, N.Y., U.S.A.) was used, with the medium tip at 60% of maximum 
output, for three cycles of sonication for 30 seconds, followed by a 30 
second interval to allow for cooling of the sample. 
Cell debris was removed by centrifugation at 34 000 rpm at 4-8°C for 30 
minutes in a Beckman Ultracentrifuge with a VTi fixed-angle or a SW 50 
swing-out rotor. 
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Supernatant, containing a crude extract of beta-lactamase, was stored at 
4°C for up to two weeks. 
(b) Estimation of beta-lactamase activity 
A rapid estimate of beta-lactamase activity (Sanders 1986, Huovinen 1988) 
was obtained by adding 0,05 ml of supernatant to 0,15 ml of 50 mg/ml 
nitrocefin (both pre-warmed to 37°C) in the well of a microtitre plate. 
Colour change was noted at 15 second intervals during incubation at 37°C 
for 15 minutes. Control wells contained nitrocefin and water or 
supernatant (as above) from an amoxycillin susceptible isolate of H. 
influenzae. 
( c) Preparation of polyacrylamide gels 
Stock solution of 25 gm acrylamide and 725 mg of N,N' -methylene-bis-
acrylamide was made up to 75 ml with distilled water, paper-filtered and 
then stored in the dark at 4°C. 
Stock solution (3,6 ml) and 0,8 ml of 40% ampholines (pl 3,5 to 9,5) were 
added to 10 ml distilled water and degassed under vacuum. 
N,N,N',N'-tetramethylethylenediamine (0,08 ml) and fresh ammomum 
persulphate (1,44 mg in 0,6 ml distilled water) were added (Seeburg 1983). 
The gel was cast onto a sheet of Gel-bond (FMC, Rockland, Maine, U.S.A.) 
between glass plates (250x100 mm) separated by a plastic gasket 1 mm 
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thick. A row of plastic tabs, stuck to the inner surface of one glass plate, 
were used to indent the upper face of the gel and form application wells. 
The gel was stored in the dark at 4 °c for 18 hours before use. 
( d) Isoelectric focusing 
Isoelectric focusing took place at 4°C in a flat-bed tank. The anode well 
contained 1 M H3P04 and the cathode well was 1 M NaOH. Crude extract 
of beta-lactamase (0,02 ml) was pipetted into each application well. 
Constant power of 10 watts was applied for two hours. 
( e) Visualisation of beta-lactamase 
After 15 minutes at 37°C the gel was overlaid to a depth of 1 mm with 2% 
agar containing 0,05 mg/ml nitrocefin (added at 42°C) and then incubated 
at 37°C. During the next hour the positions of beta-lactamases were 
revealed as a pink bands against a yellow background (Matthew 1975, 
Sanders 1986). The positions of the bands were marked on a sheet of 
transparent plastic laid over the agar. 
(f) Estimate of pl gradient 
A 1 cm wide strip was cut from the edge of the gel and divided into ten 
pieces. Each piece was immersed overnight in 2 ml of giass distilled water 
and the next day the pH of the eluate was measured with a glass-calomel-
electrodes probe pH meter. 
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Clavulanate inhibition test 
A disc approximation test (Ben Redjeb 1988) was used with the following 
modification:-
A disc containing either amoxycillin (25 microgrammes) or amoxycillin (20 
microgrammes) plus clavulanate (10 microgra~es) (Augmentin) was placed 20 
mm (disc center to disc center, 6 mm diameter discs) from a disc containing 
cefotaxime (50 microgrammes). The largest radius of the zone of growth inhibition 
abou t the cefotaxime disc was measured with a microcaliper. 
A greater increase in this radius with amoxycillin and clavulanate present, compared 
to that with amoxycillin, indicated clavulanate inhibition of beta-lactamase activity. 
RESULTS 
Selection from collected isolates 
The_ total of 93 isolates studied included 63 isolates from two defined samples: 
(1) Inpatient sample 
Isolates (29) selected at random from those collected were a 30,5% sample 
of the isolates of Enterobacter species reported in diagnostic specimens 
from Groote Schuur Hospital inpatients (Table 2). 
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(2) Surveillance sample 
Isolates (34) were from nine Groote Schuur Hospital inpatients who had, in 
each case, Enterobacter species isolated on three or . more different 
occas10ns. 
Additional isolates studied were either not report_ed (24) or were from patients in 
Woodstock Hospital (6). The latter included four isolates of E. cloacae that were 
amoxycillin susceptible. 
Identification of isolates 
For most isolates the identification made at the time of collection was confirmed. 
(Figures 5 and 6). The usual identification procedures used in the Medical 
Microbiology Laboratory do not distinguish E. taylorae and E. hormenchei from E. 
cloacae. 
The isolate of Serratia species was yellow pigmented after four days at room 
temperature on 2% blood agar. It was distinguished from E. sakazakii by sorbitol 
fermentation and decarboxylase reactions and from E. aerogenes by overnight 
production of DNAse at 37°c and anaerogenic fermentation of glucose. 
The results of most tests in the identification procedure were readily reproduced: 
O'Meara's Voges-Proskauer test gave consistent results on broth cultures incubated 
for 48 hours, but not on those incubated for 24 hours. 
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Most isolates of E. cloacae had given an alkaline reaction in Moeller's test for 
arginine decarboxylase/dehydrolase at 48 hours, but only 17 /69 had given an 
alkaline reaction at 24 hours: 
Ten isolates of E. cloacae showed no evidence of motility in hanging drop 
preparations after 4, 8, 12 and 18 hours in peptone water at 37°C. Seven of these 
isolates came from one patient. 
Seven isolates identified as E. asburiae showed frequent tumbling and infrequent 
running motility after eight hours in peptone water at 37°C. After 18 hours motility 
was absent. 
Susceptibility testing 
AJI isolates of Enterobacter species from the inpatient sample and the surveillance 
sample were susceptible to imipenem, co-trimoxazole, gentamicin and amikacin. 
Table 3 gives the results of disc diffusion susceptibility tests with beta-lactam 
antibiotics. 
The results are in groups that became evident during the study. The results for the 
isolates of E. taylorae and E. lzormanchei are included with those for E. cloacae: 
Both were resistant to amoxycillin and cefoxitin only. Isolates of E. cloacae (2) and 
E. asburiae (7) that were more susceptible to amoxycillin than E. coli (NCTC 10418) 
were as susceptible to amoX)'.cillin as Salmonella typhimurium. 
The limit prescribed for cefotaxime resistance m the disc diffusion test was 
incompatible with the diameters obtained and their bimodal distribution. (Data 
not shown). 
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This incompatibility was resolved with minimum inhibitory 
concentration (MIC) determinations. 
Cefotaxime minimum inhibitory concentration 
Figure 7 compares the cefotaxime MICs found by broth dilution and the diameters 
of the inhibition zones given by cefotaxime in disc diffusion tests for selected 
isolates. Both methods separated isolates of E. cloacae that were resistant to 
cefotaxime ( 6) from those that were susceptible (2). 
The MIG determination was repeated with two isolates. Cefotaxime resistance was 
, confirmed (MIC~ 128 mg/L) in one isolate. Interestingly, the other isolate, which 
had been cefotaxime susceptible (MIC 0,25 mg/L) showed turbid broth in tubes 
containing 0,5 , 2! 4, 16 and 32 mg/L cefotaxime but not in the intervening 1 and 8 
mg/L tubes. No growth was obtained in subcultures from the 1 and 8 mg/L tubes. 
E. cloacae that were isolated, in subcultures from the other tubes remained resistant 
(with growt.h up to the disc, in disc diffusion tests) to cefotaxime after growth on an 
antibiotic-free medium. 
Induction tests 
Results of the induction tests on isolates of E. cloacae are summarised in Table 4. 
The mean reduction in the radius of the inhibition zone about the cefamandole disc 
adjacent to cefoxitin was 2,87 mm (range 1-5 mm) and adjacent. to imipenem was 
3,10 mm (range 1-5 mm). 
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Growth of a colony of E. cloacae within the inhibition zone about the cefamandole 
disc was observed in two cefoxitin induction tests. One isolate showed cefotaxime 
resistance on direct disc diffusion susceptibility testing but after growth on an 
antibiotic-free medium this isolate was cefotaxime susceptible (and cefoxitin 
induction test positive). The other isolate retained cefotaxime resistance after 
subculture on an antibiotic-free medium. This isolate and the isolate that showed 
'skipped tubes' in the cefotaxime MIC detenp.ination (above) gave positive 
imipenem induction tests but negative cefoxitin induction tests. 
With both cefoxitin and imipenem, isolates of E. asburiae (7) were induction test 
negative whilst isolates of other Enterobacter species ( 4) were induction test positive. 
Loss of disc strength was detected on two occasions and caused 13 tests to be 
repeated. Defects in the discs were associated with improper use (imipenem left 
undesiccated and at room temperature and cefoxitin used six months past the 
manufacturer's expiry date). Once disc failure was excluded, the induction test as 
defined was readily reproduced. 
Isoelectric focusing and zymography 
Supematants that developed a red colour within ten minutes in the rapid estimate of 
beta-lactamase activity were used. 
The direction of the zone gradient on the gel was confirmed by pH measurements 
-
and by the position of the bands given by supernatants from bera-lactam resistant 
isolates of H influenzae and P. aemginosa (illustrated in Figure 8). 
25 
The supernatant from the cefotaxime resistant isolate of E. cloacae showed a single 
band on zymography. The isoelectric point was calculated to be 8,0 at this position. 
The pH of the eluate from the gel adjacent to the band was 7,9. 
Clavulanate inhibition test 
Isolates of K pneumoniae (broth dilution cefot~me MICs 16-64 mg/L) and of 
amoxycillin susceptible E. cloacae controlled the clavulanate inhibition test. 
The rune isolates of E. cloacae tested were from the nine patients who had 
cefotaxime resistant E. cloacae isolated, and included the isolate examined by 
isoelectric focusing. None of these isolates showed the marked augmentation of 
cefotaxime inhibition zones by clavulanate that was evident in the controls (Table 
5). 
Statistical analysis 
Of 83 inpatients who had E. cloacae reported in diagnostic specimens during the 
collection period and for whom work-sheets were available, eight had cefotaxime 
( or ceftriaxone) resistance recorded. In the inpatient sample of 29, there were five 
patients with cefotaxime resistant E. cloacae. 
Using the Fisher exact probability test, there is a reasonable chance (1 in 10) that in 
these two groups of patients the proportions of cefotaxime resistance are identical 
(p = 0,2296 alpha = 0,05). 
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95% confidence limits for the proportion of cefotaxime resistance obtained from 
work-sheets are 3,7% to 15,5%. A sample size of 400 would be needed to find, for 
example, 7% to 13% at a 95% probability level (Ractliffe 1967). 
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DISCUSSION 
The aims of the study were (1) to determine the proportion of isolates of 
Enterobacter cloacae from patients in Groote Schuur Hospital that are resistant to 
third-generation cephalosporins and (2) to determine this proportion using methods 
suitable for continued use in the routine laboratory. 
Resistance to cefotaxime was examined: Resistance that was permanent and due to 
constitutive hyperproduction of beta-lactamase had to be distinguished from that 
which was transient and due to induced hyperproduction of beta-lactamase 
(Livermore 1987a, Yang 1988). 
Constitutive hyperproduction of beta-lactamase was identified in isolates of E. 
cloacae that remained resistant to cefotaxime after growth in an antibiotic-free 
medium and by excluding the presence of extended-spectrum beta-lactamases 
(Phillipon 1989) using a disc approximation test of clavulanate inhibition (Brun-
Buisson 1987, Ben Redjeb 1988). A cefotaxime resistant isolate of E. cloacae, 
shown to have a characteristically basic beta-lactamase (Matthew 1975, Bush 
1989b ), cefotaxime resistant isolates of K pneumoniae and amoxycillin susceptible 
isolates of E. cloacae controlled the test. 
Clavulanate inhibition was absent in all the cefotaxime resistant isolates of E. 
cloacae tested. The test could fail in the presence of multiple beta-lactamases: 
Amoxycillin-clavulanate inhibition may be diminshed in Kl.ebsiella species and E. 
-
coli producing PSE-1 or high levels of TEM-1 or SHV-1 beta-lactamases 
(Thompson 1990). 
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The pattern of cefotaxime resistance and cefoxitin susceptibility .distinguished the 
three isolates of K pneumoniae from the cefotaxime and cefoxitin resistant isolates 
of E. cloacae. However, reduced cefoxitin susceptibility, described for OmpF 
deficient E. coli producing other TEM-3 or TEM-9 beta-lactamase (Jacoby 1990) 
and a porin deficient K pneumoniae producing TEM-3 beta-lactamase (Pangon 
1990), might obscure this distinction. 
Ideally, beta-lactamase from every isolate studied should have been examined by 
isoelectric focusing (Huovinen 1988). 
The complete correlation between cefamandole resistance and cefotaxime 
resistance was to be expected (Vu 1985, Nikaido 1987), and justifies the use of 
cefamandole as the indicator in the induction test. 
Interpretation of the induction test is problematic (Chandler 1987, Thore 1989): 
Incomplete agreement between disc approximation tests using cefoxitin as the 
inducer and those using irnipenem (Thore 1989) prompted the use of both inducers 
in this study. 
Isolates with intermediate susceptibility to cefoxitin have either had induction 
identified with a modified disc approximation test (that uses a low content cefoxitin 
disc) (Sanders 1979) or have been excluded from analysis (Chandler 1987). 
In this study, the eight cefotaxime susceptible isolates that did not give a clear 
-
correlation between the results of cefoxitin susceptibility testing -and the cefoxitin 
induction test were all imipenem induction test positive. Permanent resistance to 
cefotaxime emerged in two of these isolates, one during a disc diffusion 
susceptibility test and the other during a broth dilution test. This latter result 
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reproduces that which led to the suggestion that cefota.xime resistance might arise 
by mutation (Pindell 1976). 
If the receptor that initiates induction is periplasmic (Korfmann 1989), then limited 
access to the periplasmic space would reduce cefoxitin induction of beta-lactamase 
production, but imipenem might still have access (Hiraoka 1989) to this receptor. 
Perhaps changes in cell wall permeability (Werner 1985, Then 1986, Graham 1989, 
Hopkins 1990) might account for some of the difficulties in the interpretation of the 
induction test. 
The majority of cefotaxime susceptible isolates of E. cloacae presented no such 
difficulties. They were cefoxitin resistant and gave positive induction tests with both 
cefoxitin and imipenem. Considering that induction is part of the mechanism of 
resistance (Livermore 1987a,b, Gatus), the association between cefoxitin resistance 
and a positive cefoxitin induction test was to be anticipated and has been noted 
previously (Moritz 1986). 
In isolates of E. cloacae that were as susceptible to amoxycillin, cefoxitin and 
cefotaxime as E. coli (NCTC 10418), ampG (Korfmann 1989) may be absent. 
Amoxycillin is a strong inducer (Minami 1980a, Then 1987, Yang 1988) that, at 
periplasmic concentrations, is hydrolysed by the beta-lactamases of E. cloacae at 
rates similar to cefoxitin (Vu 1985, Galleni 1988a,b ). Amoxycillin resistance does 
not imply induction since, for example, TEM-1 beta-lactamase may be present 
(Seeberg 1983). In contrast, amoxycillin susceptibility suggests absence of 
inducibility. 
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Absence of ampC seems likely in isolates of E. cloacae and E. asburiae that were as 
susceptible to amoxycillin, cefoxitin and cefotaxime as Salmonella typhimurium 
(Lindberg 1986). 
The discussion above is summarised, in part, in Table 6, which shows the 
distribution of proposed phenotypes and genotypes for the isolates studied. 
The routine laboratory could use the inhibition and induction tests used in this study 
but, probably, they would be used as supplementary tests that followed identification 
of an isolate as E. cloacae. The incorporation of the inhibitor or inducer in the agar 
of plates inoculated during multipoint susceptibility testing is an attractive 
alternative. However, the inhibition or induction test must be clearly separated in 
concept from that of a susceptibility test: For example, the concentration of 
clavulanate required for inhibition tests may be inappropriate for susceptibility tests 
(Bush 1989a, Thompson 1990, Jacoby 1990). Furthermore, imipenem may be too 
unstable at low concentration for use as an inducer (European Study Group on 
Antibiotic Resistance 1987). 
A conclusion of this study is that patterns of susceptibility could give useful 
information about the cephalosporin resistance of E. cloacae provided borderline 
susceptibility results in the disc diffusion test are checked by MIC determinations or, 
at least, provide a starting point for further investigation: 
Cefotaxime and cefoxitin 
resistance 
-




and cefoxitin resistance 
Cefotaxime and cefoxitin 
susceptibility 
suggests inducible overproduction of beta-
lactamase 
suggests uninducible beta-lactamase 
This study confirms that a low proportion ( < 16%) of the isolates of E. cloacae from 
Groote Schuur Hospital inpatients show permanent resistance to third-generation 
cephalosporins. The sample number for a confident estimate of this proportion has 
been obtained, and highlights the danger of drawing conclusions based on small 
numbers of isolates, as has been done (Benn 1984, Ellner 1987). 
Perhaps of more importance is the observation, based on the results of the induction 
tests, that most ( 48/76) of the cefotaxime susceptible isolates of E. cloacae from 
Groote Schuur Hospital inpatients have the genetic potential for resistance to third-
generation cephalosporins. 
This aspect of the cephalosporin resistance of E. cloacae and the relative 
contributions of changes in cell wall permeability and of induced overproduction of 
beta-lactamase to this resistance warrant further investigation. 
For the present, the clinical implications of the results of this study are 
uncomprom1smg: Unnecessary use of antibiotics that select constitutive 
overproducers of beta-lactamase should be avoided (Sanders 1987). Whenever 
these antibiotics are used, provision for their failure will have to be made (Follath 
1987, Spritzer 1990). Furthermore, any source of E. cloacae within the hospital, 
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such as contaminated enteral feeds (Levy 1989) and milk powders (Biering 1989), 
must be controlled. 
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7 2 1 1 
3 2 4 3 1 1 
0 
Table 3- Susceptibility of Enterobacter species 
Isolates to Beta-lactam Antibiotics 
Susceptibility Number (o/o) of Isolates 
A B C 



























44(48) 40(53) 17(68) 
26(29) 26(34) 5(20) 
A Enterobacter species (n•91) 
B Enterobacter cloacae (n•76) 
C Inpatient sample E. cloacae (n•26) 
Table 4- Induction Tests and Cefoxitin 

















[1] See text for a description of the method and 







































































































































































































































































































































































































Table 6- Proposed Phenotype and Genotype 




Isolates sample 111 
ampR•ampC•ampD ampG• 26 6 
constitutive overproduction 
of beta-lactamase 
ampR•ampC+ampD•ampG+ 36 19 
Inducible overproduction 
of beta-lactamaae 
cefoxltln. susceptible 8 2 
and lmlpenem Inducible 
(permeability change?) 
ampR+ampC•ampD+ampG 8 1 
constitutive low production 
of beta-lactamaae 
ampC 13 0 
absent beta-lactamase 
production 































































































































































































































































































































































Fig.2- Hydrolysis of Cephalosporins by 
Beta-lactamase from E. cloacae 
Relative Rates of Hydrolysis 
2.5 ~-------------------, 2.5 
2 ~ -------·--·-·-----~ ·--------< 2 
CEFAMANDOLE 
1.5 ----------·------····--·-·-·-····---·
 ___________ ___, 1.5 
1 ---··-----·-··------- - ·-----·-·-------
-- ---- 1 
0. 5 ·-··----------··-·---------····-····-····-···· -···--·----------------· 0.5 
OL_-~~===~~::==::=:i=====t--~O 
0,1 1,0 10 100 Micromoles 
Substrate Concentration 
Data from Nikaido 1987, 1990 and Gallenl 1988 
Fig.3- Identification of Enterobacter species 
GROWTH ON MACCONKEY AGAR 
ORAM NEGATIVE BACILLUS 
OXIDASE NEGATIVE 
ACID AND OAS FROM GLUCOSE FERMENTATION 
SIMMONS CITRATE POSITIVE 
ONPO POSITIVE 
INDOLE NEGATIVE 
PHENYLALANINE DEAMINASE NEGATIVE 
HYDROGEN SULPHIDE PRODUCTION NEOATIVE 
DNASE NEOATIVE 
HANOINO DROP MOTILITY PRESENT 
OM!RAS V00!8•PROSKA!UR P081TIV! 
MOLLl!RS Tl!8TS READ AT 1, 2 AND 3 DAYS: 
ORNITHINE DECARBOXYLASE POSITIVE 
AROININE DECARBOXYLASE/ DEHYDROLASE POSITIVE 
LY81NI! Dl!CARl!IOXYLASI! Nl!OATIVI! 
80R81TOL FERMENTATION 
NO DNASE AT ROOM TEMPERATURE AT 2 AND 7 DAYS 
NO PIOMENT PRODUCTION AT ROOM TEMPERATURE 
12 hour• Incubation at 37 C, unleea Indicated 
Fig.4- Identification of Enterobacter species 
E. cloacae 
E, cioaoae Non-motile 
E. aabur!ae (few) 
E. asburiae (most) 
E. · hormaechael 
E. hormaechael 
E, tayforae 





SORB• Sorbltol fermentation 
VP• Vogea-Proakauer 
MOT+ SORB+ VP+ ARG+ 
MOT- SORB+ VP+ ARG+ 
MOT- SORB+ VP- ARG+ 
MOT- SORB+ VP- ARG-
MOT- SORB- SUC+ 
MOT+ SORB- SUC+ 
MOT+ SORB- SUC-
MOT+ SORB- delayed DNAae and 
plgment(2] 
ORN- ARG- LYS-
ORN+ ARG- LYS+ MOT+ SORB+ 
ORN+ ARG- -LYS+ MOT+ SORB-
ARG• Arginine decarboxylaae/ dehydrolaae (1) 
sue• sucrose fermentation 
ORN• Ornlthlne decarboxylaae (1) 
LYS • Lysine decarboxylase ( 1 J 
Read at (1) 1, 2 and 3 and 12] 2 and 7 days 




29 isolates collected from 29 inpatients 





















Fig.7- Cefotaxime Susceptibility 
Minimum Inhibitory Concentrations Versus 
Diameter of Inhibition Zones 
0 
0 O 




Zone diameter mm 
8 Isolates of Enterobacter cloacae 
I s
o
-e
le
c
tric
 
p
o
in
t 
6,6 
8
,5
 
8
,0
 
I F
ig
.8
-
la
o
-e
le
c
tric
 F
o
cu
sin
g
 o
f 
B
eta-lactam
ases 
-
-----
-
Lane 
1 
2 
3 
L
an
es 1
-3
: B
eta-lactam
ase fro
m
 (1) a
m
o
xycillin
 resistan
t 
H, iofluenzae, (2
) ce
fta
zid
in
e
 a
n
d
 p
ip
e
ra
cillin
 resistan
t 
P
. aeru
g
in
o
sa and (3
) cefo
taxim
e resistan
t E
. clo
acae 
